DOI:
10.1055/s-00000069
Seminars in Liver Disease
LinksClose Window
References
Gadaleta RM, van Erpecum KJ, Oldenburg B. et al.
Farnesoid X receptor activation inhibits inflammation and preserves the intestinal barrier in inflammatory bowel disease.
Gut 2011;
60 (04) 463-472
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.